These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
189 related articles for article (PubMed ID: 3674093)
1. Induction and circumvention of nitrate tolerance applying different dosage intervals. Silber S; Vogler AC; Krause KH; Vogel M; Theisen K Am J Med; 1987 Nov; 83(5):860-70. PubMed ID: 3674093 [TBL] [Abstract][Full Text] [Related]
2. The haemodynamic and anti-ischaemic effects of a single tablet of 80 mg isosorbide dinitrate in slow-release formulation and a review of nitrate tolerance. Silber S; Vogler AC; Krause KH; Theisen K Drugs; 1987; 33 Suppl 4():69-79. PubMed ID: 3622317 [TBL] [Abstract][Full Text] [Related]
3. When does nitrate tolerance develop? What dosages and which intervals are necessary to ensure maintained effectiveness? Rudolph W; Dirschinger J; Reiniger G; Beyerle A; Hall D Eur Heart J; 1988 Jan; 9 Suppl A():63-72. PubMed ID: 3137072 [TBL] [Abstract][Full Text] [Related]
4. Nitrates: why and how should they be used today? Current status of the clinical usefulness of nitroglycerin, isosorbide dinitrate and isosorbide-5-mononitrate. Silber S Eur J Clin Pharmacol; 1990; 38 Suppl 1():S35-51. PubMed ID: 2113003 [TBL] [Abstract][Full Text] [Related]
5. [Long-term therapy of stress angina pectoris by a single daily administration of 120 mg isosorbide dinitrate in retard form. Comparison of monotherapy and combination therapy with atenolol and nifedipine]. Blasini R; Brügmann U; Reiniger G; Rudolph W Herz; 1985 Jun; 10(3):163-71. PubMed ID: 3926613 [TBL] [Abstract][Full Text] [Related]
6. Comparison of the effect of isosorbide-5-mononitrate and isosorbide dinitrate in a slow-release form on exercise-induced myocardial ischemia. Hennig L; Andresen D; Hennig A; Levenson B; Brüggemann T; Schröder R J Clin Pharmacol; 1991 Jul; 31(7):636-40. PubMed ID: 1894759 [TBL] [Abstract][Full Text] [Related]
7. [Development of nitrate tolerance in individual patients with stable angina pectoris in various phases of therapy with oral isosorbide dinitrate]. Kośmicki M; Szwed H; Kowalik I; Sadowski Z Pol Merkur Lekarski; 2002 Jul; 13(73):52-5. PubMed ID: 12362508 [TBL] [Abstract][Full Text] [Related]
8. [Development of tolerance with regard to the anti-ischemic effect of isosorbide dinitrate in regular multiple daily administration]. Reiniger G; Blasini R; Brügmann U; Rudolph W Herz; 1984 Jun; 9(3):146-52. PubMed ID: 6430768 [TBL] [Abstract][Full Text] [Related]
9. Anti-ischemic effects of an 80-mg tablet of isosorbide dinitrate in sustained-release form before and after 2 weeks treatment with 80 mg once daily or twice daily. Silber S; Krause KH; Garner C; Theisen K; Jahrmärker H Z Kardiol; 1983; 72 Suppl 3():211-7. PubMed ID: 6666224 [TBL] [Abstract][Full Text] [Related]
10. What intervals in oral therapy of isosorbide dinitrate in various doses are sufficient to prevent nitrate tolerance? Kośmicki M; Sadowski Z; Szwed H; Kowalik I Med Sci Monit; 2000; 6(4):763-8. PubMed ID: 11208406 [TBL] [Abstract][Full Text] [Related]
11. Once- versus twice-daily administration of controlled-release isosorbide-5-mononitrate 60 mg in the treatment of stable angina pectoris. A randomized, double-blind, cross-over study. The Swedish Multicentre Group. Nordlander R; Walter M Eur Heart J; 1994 Jan; 15(1):108-13. PubMed ID: 8174569 [TBL] [Abstract][Full Text] [Related]
13. [4 different nitrate preparations with regard to the possible development of tolerance in long-term treatment]. Mertens HM; Ohlmeier H; Mannebach H; Kabelitz K; Gleichmann U Herz; 1985 Jun; 10(3):172-81. PubMed ID: 3926614 [TBL] [Abstract][Full Text] [Related]
14. Enhanced effectiveness of combined sustained-release forms of isosorbide dinitrate and diltiazem for stable angina pectoris. Lehmann G; Reiniger G; Haase HU; Rudolph W Am J Cardiol; 1991 Oct; 68(10):983-90. PubMed ID: 1927938 [TBL] [Abstract][Full Text] [Related]
15. [Tolerance to a sustained release form of isosorbide dinitrate: comparison between 20 mg four times and 40 mg twice-daily administrations]. Hiasa Y; Hamai K; Wada T; Ootani R; Shinohara H; Aihara T; Bando M; Nakai Y; Kataoka Y Kokyu To Junkan; 1991 Sep; 39(9):925-30. PubMed ID: 1749871 [TBL] [Abstract][Full Text] [Related]
16. Oral isosorbide dinitrate in angina pectoris: comparison of duration of action an dose-response relation during acute and sustained therapy. Thadani U; Fung HL; Darke AC; Parker JO Am J Cardiol; 1982 Feb; 49(2):411-9. PubMed ID: 7058754 [TBL] [Abstract][Full Text] [Related]
17. Effect of intervals between doses on the development of tolerance to isosorbide dinitrate. Parker JO; Farrell B; Lahey KA; Moe G N Engl J Med; 1987 Jun; 316(23):1440-4. PubMed ID: 3574424 [TBL] [Abstract][Full Text] [Related]
18. Isosorbide 5-mononitrate: a review of a sustained-release formulation (Imdur) in stable angina pectoris. Gunasekara NS; Noble S Drugs; 1999 Feb; 57(2):261-77. PubMed ID: 10188765 [TBL] [Abstract][Full Text] [Related]
19. Duration of effects and tolerance of slow-release isosorbide-5-mononitrate for angina pectoris. Thadani U; Hamilton SF; Olson E; Anderson JL; Prasad R; Voyles W; Doyle R; Kirsten E; Teague SM Am J Cardiol; 1987 Apr; 59(8):756-62. PubMed ID: 3825935 [TBL] [Abstract][Full Text] [Related]
20. Circadian investigation of interval therapy with isosorbide dinitrate in coronary heart disease. Wortmann A; Bachmann K; Meinhold M Eur Heart J; 1988 Jan; 9 Suppl A():119-24. PubMed ID: 3409908 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]